4th ADC Linker and Conjugation Summit

The 4th ADC Linker and Conjugation Summit in Boston brings together medicinal chemists, bioconjugation specialists, and drug developers to advance the science of antibody-drug conjugates — one of oncology's most active innovation areas. Topics include linker design and stability, bioconjugation chemistries, high-DAR constructs, degrader-antibody conjugates, off-target toxicity mitigation, and the translational path from ADC design to clinical candidate. The summit provides an intensive, practitioner-focused forum for connecting chemistry innovation with clinical success.

adc adcdesign bioconjugation chemistry conjugation degrader-antibodyconjugates high-darconstructs linker off-targettoxicity